13266-82-5 (九水合草酸钇(III),Yttrium(III) oxalate nonahydrate)

CAS号:
13266-82-5
中文名称:
九水合草酸钇(III)
英文名称:
Yttrium(III) oxalate nonahydrate
分子式:
C6H18O21Y2
分子量:
604.006231784821

九水合草酸钇(III)(13266-82-5)名称与标识符

名称

中文别名:
九水合草酸钇(III);九水合草酸钇(III) (REO);1-溴己烷-d13;草酸铈(III)水合物;草酸钇;草酸钇(III)九水合物;九水合草酸钇;草酸钇九水;草酸钇九水合物;九水合草酸钇(III), 99.9%;九水合草酸钇(III), 99.9% (REO);
英文别名:
Yttrium(III) oxalate nonahydrate;YttriumoxalatenonahydrateREOwhitextl;AC1MJ1Z3;AG-D-66397;CTK8E1910;diyttrium(3+) nonahydrate trioxalate ion;FT-0636859;nonahydrate;oxalate;YTTRIUM OXALATE;YTTRIUM(III) OXALATE;YTTRIUM OXALATE REAGENT;YTTRIUM OXALATE, HYDROUS;YTTRIUM OXALATE NONAHYDRATE;YTTRIUM OXALATE, 99.95%;YTTRIUM OXALATE, 99.99%;YTTRIUM OXALATE HYDRATE 99.999%;YTTRIUM (III) OXALATE 99.99% (REO);oxalate;yttrium(3+);nonahydrate;Yttrium, [.mu.-[ethanedioato(2-)-O,O''':O',O'']]bis[ethanedioato(2-)-O,O']di-, nonahydrate;Yttrium ethanedioate--water (2/3/9);DTXSID00927763;Yttrium, (mu-(ethanedioato(2-)-O,O''':O',O''))bis(ethanedioato(2-)-O,O')di-, nonahydrate;13266-82-5;Yttrium, [mu-[ethanedioato(2-)-kappaO1,kappaO'2:O2,O'1]]bis[ethanedioato(2-)-kappaO1,kappaO2]di-, hydrate (1:9);CTXJKXXQOORSKU-UHFFFAOYSA-H;

标识符

MDL:
MFCD00150502
InChIKey:
CTXJKXXQOORSKU-UHFFFAOYSA-H
Inchi:
1S/3C2H2O4.9H2O.2Y/c3*3-1(4)2(5)6;;;;;;;;;;;/h3*(H,3,4)(H,5,6);9*1H2;;/q;;;;;;;;;;;;2*+3/p-6
SMILES:
[Y+3].[Y+3].[O-]C(C(=O)[O-])=O.[O-]C(C(=O)[O-])=O.[O-]C(C(=O)[O-])=O.O.O.O.O.O.O.O.O.O

九水合草酸钇(III)(13266-82-5)物化性质

实验特性

  • LogP : -2.99580
  • PSA : 157.80000
  • 水溶性 : Insoluble in water, moderately soluble in strong mineral acids
  • 沸点 : 365.1 °C at 760 mmHg
  • 熔点 : decomposes [AES93]
  • 蒸气压 : No date available
  • 闪点 : 188.8 °C
  • 颜色与性状 : 白色晶体。
  • 溶解性 : 未确定
  • 密度 : g/cm3

计算特性

  • 精确分子量 : 441.75100
  • 氢键供体数量 : 9
  • 氢键受体数量 : 21
  • 可旋转化学键数量 : 3
  • 同位素质量 : 441.751
  • 重原子数量 : 29
  • 复杂度 : 60.5
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 14
  • 疏水参数计算参考值(XlogP) : 无
  • 互变异构体数量 : 无
  • 表面电荷 : 0
  • 拓扑分子极性表面积 : 241A^2

九水合草酸钇(III)(13266-82-5)安全信息

九水合草酸钇(III)(13266-82-5)相关文献

九水合草酸钇(III)(13266-82-5)参考资料

Reaxys RN:
PubChem CID:

九水合草酸钇(III)(13266-82-5) MSDS

基础信息


Section 1: Product Identification
   Chemical Name:       Yttrium (III) oxalate hydrate (99.9%-Y) (REO)    
   CAS Registry Number:       13266-82-5    
   Formula:       Y2(C2O4)3.xH2O    
   EINECS Number:       none    
   Chemical Family:       salt of an organic acid    
   Synonym:       Ethanedioic acid, yttrium salt; Oxalic acid, yttrium salt    

Section 2: Composition and Information on Ingredients
   Ingredient       CAS Number       Percent       ACGIH (TWA)       OSHA (PEL)    
   Title Compound       13266-82-5       100%       1mg/m3 (as Y)       1mg/m3 (as Y)    

Section 3: Hazards Identification
   Soluble oxalates are harmful if swallowed. They precipitate calcium from the bloodstream causing violent
   Emergency Overview:
   muscular stimulation, convulsions, collapse, and death.
   Primary Routes of Exposure:       Ingestion, Inhalation of dust.    
   Eye Contact:       May cause moderate to severe irritation of the eyes.    
   Skin Contact:       May cause moderate to severe irritation of the skin.    
   Inhalation:       Dust may be severely irritating to the nose, mucous membranes and respiratory tract.    
   Harmful if swallowed. Ingestion may cause vomiting, pain, violent muscular stimulation, convulsions, collapse
   Ingestion:
   and death.
   Soluble oxalates remove calcium from the bloodstream. This interferes with the central nervous system
   Acute Health Affects:
   causing violent convulsions and death.
   Prolonged exposure to oxalates can lead to kidney failure resulting from calcium oxalate precipitation in renal
   Chronic Health Affects:
   tubes
   NTP:       No    
   IARC:       No    
   OSHA:       No    

SECTION 4: First Aid Measures
   Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
   Eye Exposure:
   assistance in keeping their eye lids open. Get immediate medical attention.
   Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
   Skin Exposure:
   irritation persists.
   Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
   Inhalation:
   in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
   Antidotes are said to be soluble calcium given orally, and calcium gluconate given intravenously, to be
   Ingestion:
   administered by trained medical personnel. Keep the victim calm. Give the victim water (only if conscious).

SECTION 5: Fire Fighting Measures
   Flash Point:       not applicable    
   Autoignition Temperature:       none    
   Explosion Limits:       none    
   Extinguishing Medium:       carbon dioxide, dry powder or foam    
   If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained
   Special Fire Fighting Procedures:
   breathing apparatus and full protective clothing.
   Hazardous Combustion and       If involved in a fire this material may emit toxic organic fumes and carbon monoxide.    
   Decomposion Products:
   Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
   Spill and Leak Procedures:       Small spills can be mixed with vermiculite or sodium carbonate and swept up.    

SECTION 7: Handling and Storage
   Handling and Storage:       Store in a sealed container. Keep away from heat and moisture.    

SECTION 8: Exposure Controls and Personal Protection
   Eye Protection:       Always wear approved safety glasses when handling a chemical substance in the laboratory.    
   Skin Protection:       Wear appropriate chemical resistant gloves and protective clothing.    
   Ventilation:       Material may form a fine dust. If possible, handle the material in an efficient fume hood.    
   If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators
   Respirator:
   requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134.
   Ventilation:       Material may form a fine dust. If possible, handle the material in an efficient fume hood.    
   Additional Protection:       No additional protection required.    

SECTION 9: Physical and Chemical Properties
   Color and Form:       white xtl.    
   Molecular Weight:       441.87    
   Melting Point:       no data    
   Boiling Point:       no data    
   Vapor Pressure:       not applicable    
   Specific Gravity:       no data    
   Odor:       none    
   Solubility in Water:       slightly soluble    

SECTION 10: Stability and Reactivity
   Stability:       air and moisture stable solid    
   Hazardous Polymerization:       no hazardous polymerization    
   Conditions to Avoid:       none    
   Incompatibility:       oxidizing agents, concentrated sulfuric acid    
   Decomposition Products:       Carbon dioxide, carbon monoxide, organic vapors, soot, and metal oxides and carbonates.    

SECTION 11: Toxicological Information
   RTECS Data:       No information available in the RTECS files.    
   Carcinogenic Effects:       No data available    
   Mutagenic Effects:       No data available    
   Tetratogenic Effects:       No data available    

SECTION 12: Ecological Information
   Ecological Information:       No information available    

SECTION 13: Disposal Considerations
   Disposal:       Dispose of according to local, state and federal regulations.    

SECTION 14: Transportation
   Shipping Name (CFR):       Non-hazardous    
   Hazard Class (CFR):       NA    
   Additional Hazard Class (CFR):       NA    
   Packaging Group (CFR):       NA    
   UN ID Number (CFR):       NA    
   Shipping Name (IATA):       Non-hazardous    
   Hazard Class (IATA):       NA    
   Additional Hazard Class (IATA):       NA    
   Packaging Group (IATA):       NA    
   UN ID Number (IATA):       NA    

SECTION 15: Regulatory Information
   TSCA:       Not listed in the TSCA inventory.    
   SARA (Title 313):       Title compound not listed.    
   Second Ingredient:       none    


SECTION 16 - ADDITIONAL INFORMATION
N/A